The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (108.60) USD. With the latest stock price at 12.03 USD, the upside of FibroGen Inc based on DCF is -1002.7%.
Based on the latest price of 12.03 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 1002.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 17.6% | 11.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (839.62) - (67.53) | (108.60) |
| Upside | -7079.4% - -661.3% | -1002.7% |